Common Heartburn Meds Show Ties to Kidney Trouble

SATURDAY, Nov. 4, 2017 -- If you're one of the millions of Americans who takes one of a class of anti-reflux meds such as Nexium, Prilosec and Prevacid, take heed: These drugs have been linked to higher odds of kidney trouble. The study couldn't...
Source: - Daily MedNews - Category: General Medicine Source Type: news

Related Links:

Authors: Hoshikawa Y, Sawada A, Sonmez S, Nikaki K, Woodland P, Yazaki E, Sifrim D Abstract Background/Aims: Mean nocturnal baseline impedance (MNBI) during multichannel intraluminal impedance pH-monitoring (MII-pH) reflects the status of esophageal mucosal integrity. MNBI is suggested as an adjunctive method to distinguish patients with true gastroesophageal reflux disease (GERD) from functional heartburn (FH) and might predict outcomes for anti-reflux treatment. However, current methodology for calculation of MNBI is time-consuming and subject to operator-dependent selection bias. We aim to simplify and provide a...
Source: Journal of Neurogastroenterology and Motility - Category: Gastroenterology Tags: J Neurogastroenterol Motil Source Type: research
Update: On April 1, 2020, the FDA requested manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine drugs (Zantac, others) from the market immediately, due to the presence of a contaminant known as N-Nitrosodimethylamine (NDMA). Although the FDA did not observe unacceptable levels of NDMA in many of the samples they tested, they have determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures. As a result of this recall, ranitidine products will no longer be available for prescription or OTC use in the US. The FDA is also advising co...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Digestive Disorders Drugs and Supplements Source Type: blogs
Title: FDA Pulls Heartburn Drug Zantac From MarketCategory: Health NewsCreated: 4/1/2020 12:00:00 AMLast Editorial Review: 4/2/2020 12:00:00 AM
Source: MedicineNet Digestion General - Category: Nutrition Source Type: news
New findings about N-Nitrosodimethylamine (NDMA) contamination of this type of heartburn medication led to the U.S. Food and Drug Administration's (FDA's) more drastic action.
Source: Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
Six months after independent testing first raised the possibility that popular heartburn drug ranitidine (Zantac) might break down into the powerful carcinogen n-nitrosodimethylamine (NDMA), the FDA has asked for the removal of all ranitidine products from the market.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Heartburn medication made by Sanofi of France has been linked to cancer-causing impurity
Source: - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
FDA orders drugmakers to pull popular heartburn medications that contain trace amounts of a carcinogen.
Source: Health News: - Category: Consumer Health News Source Type: news
The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday.
Source: - Health - Category: Consumer Health News Source Type: news
The U.S. Food and Drug Administration is telling drugmakers to immediately pull a type of heartburn drug off the market due to contamination with a chemical that may cause cancer
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
WEDNESDAY, April 1, 2020 -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable human carcinogen, the U.S. Food and Drug Administration said Wednesday. This is...
Source: - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Esomeprazole | General Medicine | Heartburn | Lansoprazole | Nexium | Omeprazole | Prevacid | Prilosec | Study | Urology & Nephrology